Alexey Seregin (Alex Goraltchouk)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Knee Osteoarthritis

Top Venues

Current gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Judith M Hollander, Alexey Seregin, Jingshu Liu, Ellyn Xu, Francesco Luppino, Timothy E McAlindon, Li Zeng, Alexey Seregin
Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis. Current gene therapy 24 (4) (2024)
Judith M Hollander, Alexey Seregin, Jingshu Liu, Ellyn Xu, Francesco Luppino, Timothy E McAlindon, Li Zeng, Alexey Seregin
Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis. Current gene therapy 24 (4) (2024)
Judith M Hollander, Alexey Seregin, Jingshu Liu, Ellyn Xu, Francesco Luppino, Timothy E McAlindon, Li Zeng, Alexey Seregin
Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis. Current gene therapy 24 (4) (2024)
Judith M Hollander, Alexey Seregin, Jingshu Liu, Ellyn Xu, Francesco Luppino, Timothy E McAlindon, Li Zeng, Alexey Seregin
Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis. Current gene therapy 24 (4) (2024)
Judith M Hollander, Alex Goraltchouk, Miraj Rawal, Jingshu Liu, Francesco Luppino, Li Zeng, Alexey Seregin
Adeno-Associated Virus-Delivered Fibroblast Growth Factor 18 Gene Therapy Promotes Cartilage Anabolism. Cartilage (2023)